Business
Elanco Releases 2024 Impact Report and Introduces New Framework
GREENFIELD, IN / ACCESS Newswire / June 26, 2025 / Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report, showcasing its efforts to enhance animal care, not just improving the lives of animals but also ...
About this update from Elanco Animal Health Incorporated
[{"type":"text","content":"GREENFIELD, IN / ACCESS Newswire / June 26, 2025 / Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report, showcasing its efforts to enhance animal care, not just improving the lives of animals but also the people who care for them. Reflecting on its purpose and strategic alignment, the report introduces a new framework centered on four key communities of impact, celebrating Elanco's culture of 'Going Beyond' for animals, customers, society, and our people.","length":520,"tagName":"p"},{"type":"text","content":"In launching a new approach to impact reporting, Elanco reaffirms its dedication to delivering lasting positive change. The report outlines eight core ambitions that shape Elanco's business and aim to generate a meaningful impact within the communities we serve worldwide.","length":276,"tagName":"p"},{"type":"text","content":""Elanco is dedicated to delivering positive impact through the work we do every day, bringing innovative solutions to veterinarians, farmers, and pet owners," said Jeff Simmons, President & CEO of Elanco. "We're proud to announce a new framework that further embeds our purpose within our business operations, driving growth, accountability, and lasting positive change for society. We celebrate the progress made for these communities of impact and remain committed to advancing our objectives while delivering meaningful value to all our stakeholders."","length":582,"tagName":"p"},{"type":"text","content":"Key Highlights include:","length":23,"tagName":"p"},{"type":"text","content":"Go Beyond for Animals: Our strong portfolio, high-impact innovation, unique market approach, and dedication to making life better compels us to Go Beyond for Animals.","length":166,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Brought key innovations to market, such as Zenrelia, Credelio Quattro, and Pradalex, driving $461 million in revenue in 2024, surpassing our innovation revenue contribution target of $420 million to $450 million.","length":212,"tagName":"p"}]},{"val":[{"type":"text","content":"Increased pet owner access to parasite protection: Ranked as #1 retail parasiticide dispensing in the U.S. while expanding global retail offerings with AdTab and the U.S. launch of Pet Protect, a new line of veteri...